CellCyte Genetics to Present at 2008 San Francisco RedChip Small-Cap Investor Conference

BOTHELL, Wash., June 4 CellCyte GeneticsCorporation's (CellCyte) (OTC Bulletin Board: CCYG) President and CEO, Gary A.Reys, will present at the 2008 San Francisco RedChip Small-Cap InvestorConference on Thursday, June 5, at 10:35 AM Pacific Daylight Time at thePalace Hotel in San Francisco. In addition, CellCyte will have a booth at theconference at which they will have a prototype demonstration of the Company'scell expansion bioreactor.

The presentation will be Web cast live with slides and archived for replayafter the presentation at:http://www.redchip.com/visibility/conferencePages/SanFran2008/conferenceMain.asp?page=webcast

About CellCyte Genetics

CellCyte Genetics Corporation is a biotechnology company engaged in thediscovery, development and commercialization of stem cell enabling therapeuticproducts. CellCyte is developing products to allow more efficient delivery andincreased retention of adult stem cells to diseased organs, such as the heart.The goal of these therapies is to increase the number of stem cells deliveredto a damaged organ, thereby markedly increasing organ healing and functionalrestoration. The Company's lead product in development, CCG-TH30, is designedto send autologous bone marrow-derived (adult) stem cells to the heart ofpatients after a heart attack.CellCyte Genetics | 1725 220th Street SE | Bothell | Washington | 98021 | USA For further information see: http://www.cellcyte.com. Symbol: OTCBB - CCYG; Frankfurt/Berlin Symbol - LK6 WKN. No.: A0MLCV.

SOURCE CellCyte Genetics Corporation

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...